85 related articles for article (PubMed ID: 3913197)
1. [Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status].
Vogel J; Oehr P; Totović V; Bellmann O; Dworak O
Verh Dtsch Ges Pathol; 1985; 69():226-31. PubMed ID: 3913197
[No Abstract] [Full Text] [Related]
2. [The hormone receptor content of breast cancers. Comparison of morphologic and biochemical methods of determination].
Neumann K; Rüschoff J; Horstmann A; Zwiorek L; Kalbfleisch H
Pathologe; 1989 May; 10(3):160-4. PubMed ID: 2662167
[No Abstract] [Full Text] [Related]
3. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
4. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of lectin receptor and carcinoembryonic antigen in the cancerous and non-cancerous tissues in the human breast].
Zheng Z
Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):353-6. PubMed ID: 1337891
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical detection of CEA in metastasizing breast cancers with "normal" and absorbed commercial antiserum].
Merkel KH; Neis KJ; Hinkeldey A
Verh Dtsch Ges Pathol; 1985; 69():222-5. PubMed ID: 3913196
[No Abstract] [Full Text] [Related]
7. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
8. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
[TBL] [Abstract][Full Text] [Related]
9. [Statistical analysis of lectin and hormone receptor findings in 306 breast cancers].
Hülter FW; Schumacher M; Kunze WP
Verh Dtsch Ges Pathol; 1985; 69():359-61. PubMed ID: 3006386
[No Abstract] [Full Text] [Related]
10. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
12. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P
Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
[TBL] [Abstract][Full Text] [Related]
13. [CEA and TPA in cancer of the breast. Findings and criteria of use].
Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V
Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
[TBL] [Abstract][Full Text] [Related]
15. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
[TBL] [Abstract][Full Text] [Related]
16. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
[TBL] [Abstract][Full Text] [Related]
17. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
Lüthgens M; Schlegel G
Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
[TBL] [Abstract][Full Text] [Related]
18. [Immunocytochemical detection of the estrogen receptor and lectin binding sites in tumor cell colonies growing in vitro].
Werner A; Bellmann O; Vogel J; Kurbacher C; Nagel W; Diedrich K; Krebs D
Geburtshilfe Frauenheilkd; 1988 May; 48(5):299-304. PubMed ID: 3294084
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
[No Abstract] [Full Text] [Related]
20. Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features.
van der Linden JC; Baak JP; Lindeman J; Smeulders AW; Meyer CJ
Histopathology; 1985 Oct; 9(10):1051-9. PubMed ID: 4085979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
